Literature DB >> 10938526

Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).

N Jaulin1, M Appel, C Passirani, G Barratt, D Labarre.   

Abstract

Amphiphilic and fluorescent covalently labelled core-shell nanoparticles based on poly(methyl methacrylate) (PMMA), were prepared by random copolymerisation of N-Vinyl carbazole (NVC) with MMA, initiated on polysaccharidic radicals, yielding diblock copolymers of either dextran-P(MMA-NVC) (Nanodex* particles), or heparin-P(MMA-NVC) (Nanohep* particles). Nanoparticles made from random copolymers of P(MMA-NVC) (PMMA*) were used as controls. The interactions between particles and a J774A1 murine macrophage-like cell line were quantified by direct measurement of the cell-associated fluorescence. The association with the cells occurred within 30 min. Nanodex* and Nanohep* showed considerably less association than the control PMMA* particles. Some of the particle uptake could be attributed to phagocytosis, but more than 50% of the cell-associated fluorescence persisted at low temperature or in the presence of cytochalasin B. The results suggest that both the adsorption and the internalisation processes can be inhibited by the presence of the polysaccharide chains. In conclusion, these results confirm that nanoparticles prepared with heparin or dextran chains on their surface, probably in a brush-like configuration, show "stealth" properties in vitro as had previously been observed in vivo. If this biomimetic approach can also be applied to biodegradable polymers, these systems would provide at least an alternative to PEG-modified particles as long-circulating drug carriers systems or imaging agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938526     DOI: 10.3109/10611860008996862

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  9 in total

Review 1.  Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

Authors:  Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-15       Impact factor: 4.939

Review 2.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

3.  Protection of opening lids: very high catalytic activity of lipase immobilized on core-shell nanoparticles.

Authors:  Xuefei Sun; Weipu Zhu; Krzysztof Matyjaszewski
Journal:  Macromolecules       Date:  2018-01-01       Impact factor: 5.985

4.  Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.

Authors:  Sanaul Mustafa; V Kusum Devi; Roopa S Pai
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

5.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

6.  In vitro evaluation of poly(caporlactone) grafted dextran (PGD) nanoparticles with cancer cell.

Authors:  P Prabu; Atul A Chaudhari; Santosh Aryal; N Dharmaraj; S Y Park; W D Kim; H Y Kim
Journal:  J Mater Sci Mater Med       Date:  2007-11-28       Impact factor: 3.896

7.  Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems.

Authors:  Charalambos Tsagogiorgas; Friedrich Anger; Grietje Beck; Annette Breedijk; Benito Yard; Simone Hoeger
Journal:  Drug Des Devel Ther       Date:  2019-06-27       Impact factor: 4.162

8.  Revolutionary impact of nanodrug delivery on neuroscience.

Authors:  Reza Khanbabaie; Mohsen Jahanshahi
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

9.  Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.

Authors:  Angelica Sette; Jolanda Spadavecchia; Jessem Landoulsi; Sandra Casale; Bernard Haye; Olivia Crociani; Annarosa Arcangeli
Journal:  J Nanopart Res       Date:  2013-11-16       Impact factor: 2.253

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.